Latest From Biotech Now

Special 301: BIO Highlights Challenges in India

cells115x76

BIO recently testified before the U.S. government on the intellectual property challenges our members face in various markets around the world. Among other matters, BIO recommended that the U.S. government designate India as a Priority Foreign Country, a designation that would lead to the consideration of trade sanctions for treaty violations. Specifically, BIO testified: “In the healthcare space, only a few dozen innovative and patent protected medicines are on the market in India. Yet, in Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BioNJ Streamlines Clinical Trials Agreement Process

bionj3

Biotechnology companies face monumental challenges – from containing R&D costs to managing sales and marketing to compliance with regulatory bodies. Biotech startups often operate with just a few employees, all of whom tend to pull double duty, both in the lab and front office. With that in mind, BioNJ has produced a free document available to companies (not just New Jersey-based ) interested in streamlining the often time-consuming process of negotiating clinical trial agreements. The Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , ,

Post-Con BIO CEO Company Snapshot: Immunovaccine

Immunovaccine-logo-PMS

A few weeks ago, the BIO CEO & Investor Conference concluded in New York City. With a 30% increase in One-on-One Partnering meetings and sold out company presentations, industry execs gathered to do business, and hear the latest from innovative companies. As a precursor to the event, the company snapshot campaign highlighted a few of the companies who would be participating onsite. This year, the snapshot feature concludes with an interview from Marc Mansour, Ph.D., Chief Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , ,

GMO Answers Piece “Random Thoughts etc”

GMOAnslogo

The Lowdown on GMOs: According to Science, compiled by Fourat Janabi, features contributions by public scientists, authors, farmers, science writers and journalists who answer the hard questions surrounding GMOs. It is “THE book on GMOs” intended to counter fabricated and destructive activism permeating the biotech discussion based on little more than anecdote and ideology. As an independent expert, Janabi does a notable job of collecting reliable content from reputable and credible GMO experts that can Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Partnership for Part D Access Launches Today

BIO-logo-115x76

BIO joins patient groups and other health care stakeholders today to announce the formation of the Partnership for Part D Access, a coalition committed to protecting access to necessary medications for patients in the Medicare Part D prescription drug program. The Partnership for Part D Access opposes a proposed rule from the U.S. Centers for Medicare & Medicaid Services (CMS) that would reduce the number of “protected classes” of medication in Medicare Part D, specifically Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,